FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents pharmaceutical composition for treatment of infectious diseases caused by multi-resistant bacteria, which is characterised by the fact that it contains aztereonam with L-arginine and sulbactam in ratio 1:1.
EFFECT: invention ensures treatment of infectious diseases caused by multi-resistant bacteria.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR TREATING INFECTIOUS DISEASES CAUSED BY MULTIRESISTANT BACTERIA | 2006 |
|
RU2377985C2 |
| AGENT FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-RESISTANT BACTERIA, INCLUDING THOSE PRODUCING CARBAPENEMASE | 2022 |
|
RU2793587C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS CAUSED BY THE MAIN PATHOGENS | 2023 |
|
RU2825961C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
| METHOD FOR IDENTIFICATION OF NOSOCOMIAL OPPORTUNISTIC INFECTIONS PATHOGENS AND MARKERS OF THEIR RESISTANCE TO BETA-LACTAM ANTIBIOTICS AND GLYCOPEPTIDES IN WOMEN OF REPRODUCTIVE AGE AND NEWBORN CHILDREN FOR ANTIBACTERIAL THERAPY OPTIMISATION | 2016 |
|
RU2629322C1 |
| MEDICATION FOR TREATMENT OF INFECTIOS DISEASES | 2010 |
|
RU2424801C1 |
| ANTIMICROBIAL COMBINATION FOR CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA OF THE TYPE KLEBSIELLA PNEUMONIAE PRODUCING METAL-Β-LACTAMASE | 2016 |
|
RU2664434C2 |
| ANTIMICROBIAL COMBINATION FOR CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA OF THE SPECIES ACINETOBACTER BAUMANNII PRODUCING METAL-β-LACTAMASE | 2016 |
|
RU2666619C2 |
| INTENDED FOR INJECTION COMPOSITIONS FOR OVERCOMING BETA-LACTAMASE-MEDIATED RESISTANCE TO ANTIBIOTICS WITH APPLICATION OF BETA-LACTAMASE INHIBITOR | 2005 |
|
RU2397768C2 |
| METHOD OF ASSAY OF MYCOBACTERIAL BETA-LACTAMASE ACTIVITY | 1992 |
|
RU2117045C1 |
